Texas awards $15.4 million to Southlake biotech firm for new cancer treatment
from The Dallas Morning News
A Southlake biotech company is receiving its second multimillion-dollar boost from Texas' cancer-fighting agency to assist in developing a treatment for cancers caused by the human papilloma virus. OncoNano Medicine pulled in $15.4 million in the latest round of funding approved by the Cancer Prevention and Research Institute of Texas. It's part of more than $36 million awarded to Dallas-Fort Worth researchers and health care institutions. An additional $1.95 million will go toward prevention efforts in East Texas.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063